← Open Payments lookup

MELISSA DELAFUENTE GONZALEZ: Open Payments

NPI 1306141312 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$748 in 30 payments from 12 companies in 2025. Trend: 2023 $64 · 2024 $489 · 2025 $748

Food & beverage: $748
CompanyPaymentsAmount
Novo Nordisk Inc11$244
Boehringer Ingelheim Pharmaceuticals, Inc.5$149
Dexcom, Inc.4$141
Endologix LLC1$68
Bayer Healthcare Pharmaceuticals Inc.2$38
GlaxoSmithKline, LLC.1$17
Lundbeck LLC1$17
AstraZeneca Pharmaceuticals LP1$16
Lilly USA, LLC1$15
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$15

Products named: Ozempic, DEXCOM G7 GSS (161), ENDOCROSS Device, Kerendia, Rybelsus, JARDIANCE, SHINGRIX, REXULTI.

Industry payments across TX — which companies pay providers there.